Cutaneous lupus erythematosus (CLE) is associated with an increased risk for atherosclerotic cardiovascular disease (ASCVD).
The following is a summary of “Interferon-α biological activity is associated with disease activity and risk of flare in cutaneous lupus erythematosus: a monocentric study of 184 patients,” published ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback